0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint | 
Paul C. Mullan, MD, MPH; David O. Kessler, MD, MSc; Adam Cheng, MD, FRCPC
JAMA. 2014;312(22):2333-2334. doi:10.1001/jama.2014.15741.

Research Letter | 
Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS; Brittney Frankel, BA; et al.
JAMA. 2014;312(20):2163-2165. doi:10.1001/jama.2014.13329.

The Art of JAMA | 
Carrie A. Butt
JAMA. 2014;312(17):1722-1723. doi:10.1001/jama.2013.279811.

The Art of JAMA | 
Jeanette M. Smith, MD
JAMA. 2014;312(12):1180-1181. doi:10.1001/jama.2013.279741.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(12):1185. doi:10.1001/jama.2014.12756.

Review | 
Kyle D. Checchi, MSc; Krista F. Huybrechts, MS, PhD; Jerry Avorn, MD; et al.
JAMA. 2014;312(12):1237-1247. doi:10.1001/jama.2014.10059.
Includes: CME, Supplemental Content

From the JAMA Network | 
Charles Ruetsch, PhD
JAMA. 2014;312(11):1145-1146. doi:10.1001/jama.2014.4318.

Medical News & Perspectives | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(11):1086-1087. doi:10.1001/jama.2014.11153.

Original Investigation | 
Massimo Imazio, MD; Antonio Brucato, MD; Paolo Ferrazzi, MD; et al.
JAMA. 2014;312(10):1016-1023. doi:10.1001/jama.2014.11026.
Includes: Supplemental Content

From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2014;312(9):955-957. doi:10.1001/jama.2014.10644.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
From The JAMA Network
JAMA Psychiatry
Editorial  | 
Why Are Benzodiazepines Not Yet Controlled Substances?
Nicholas Moore, MD, PhD; Antoine Pariente, MD, PhD; Bernard Bégaud, MD, PhD
JAMA Psychiatry
Original Investigation  | 
Benzodiazepine Use in the United States
Mark Olfson, MD, MPH; Marissa King, PhD; Michael Schoenbaum, PhD
JAMA Internal Medicine
Research Letter  | 
Effect of Public Disclosure on Antibiotic Prescription Rate for Upper Respiratory Tract Infections
Jae Moon Yun, MPH; Dong Wook Shin, MD, DrPH, MBA; Seung-sik Hwang, MD, PhD; et al.
JAMA Dermatology
Observation  | 
Fanconi Syndrome Induced by Vemurafenib:  A New Renal Adverse Event
Daphné Denis, MD; Nathalie Franck, MD; Fanny Fichel, MD; et al.